Universe Pharmaceuticals Inc. (UPC) Stock Overview
Explore Universe Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.
Universe Pharmaceuticals Inc. (UPC)
Key Financials
Key Financials
Market Cap
3.8M
P/E Ratio
-1.65
EPS (TTM)
$-8.06
ROE
-0.03%
UPC Stock Analysis & Investment Overview (NASDAQ)
Our AI-powered analysis of Universe Pharmaceuticals Inc. (NASDAQ: UPC) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, Universe Pharmaceuticals Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.
The current technical analysis of UPC on the NASDAQ shows an RSI of 55.76, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $0.46 for the NASDAQ listing.
Key metrics behind Universe Pharmaceuticals Inc.'s NASDAQ-traded stock include a P/E ratio of -1.65 and a market capitalization of 3.8M. Combined with our AI analysis, these give both institutional and retail investors a clear view of UPC on the NASDAQ.